Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-over Study to Evaluate the Safety, Tolerability, and Clinical Efficacy of Transcranial Alternating Current Stimulation (tACS) in Patients With Frontotemporal Dementia

NCT07505784 is registered in ClinicalTrials.gov with IRCCS Centro San Giovanni di Dio Fatebenefratelli as lead sponsor.

NCT NCT07505784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07505784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-over Study to Evaluate the Safety, Tolerability, and Clinical Efficacy of Transcranial Alternating Current Stimulation (tACS) in Patients With Frontotemporal Dementia
Lead sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Phase
Not applicable
Overall status
Recruiting
Start date
February 3, 2026
Completion date
February 28, 2027
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

frontotemporal dementia (ftd), transcranial alternating current stimulation